SCHEMBL6437249

SCHEMBL6437249

O=C(NC1CC1)C(c1ccccc1)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.62
CCR1 P32246 2/20 0.61
ALDH1A1 P00352 1/20 0.58
HDAC3 O15379 1/20 0.57
HDAC4 P56524 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC7 Q8WUI4 1/20 0.57
HDAC2 Q92769 1/20 0.57
HDAC10 Q969S8 1/20 0.57
HDAC11 Q96DB2 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
HDAC9 Q9UKV0 1/20 0.57
HDAC5 Q9UQL6 1/20 0.57
CTSD P07339 1/20 0.55
TSHR P16473 2/20 0.53
MAPT P10636 1/20 0.51
GRM7 Q14831 2/20 0.50
C3AR1 Q16581 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14050745 0.91 CCR1 (0.68) POLBCCR1ALDH1A1TSHR
SCHEMBL11094731 0.88 POLB (0.55) POLBCCR1ALDH1A1HDAC3HDAC4
SCHEMBL11226541 0.88 POLB (0.58) POLBCCR1ALDH1A1HDAC3HDAC4
SCHEMBL6159618 0.82 POLB (0.56) POLBCCR1ALDH1A1HDAC3HDAC4
SCHEMBL7242918 0.82 DRD4 (0.61) POLBCCR1ALDH1A1TSHRC3AR1
SCHEMBL25464181 0.81 GRM7 (0.73) TSHRGRM7
SCHEMBL8225263 0.81 GRM7 (0.73) TSHRGRM7
SCHEMBL998303 0.81 TSHR (0.50) CCR1ALDH1A1TSHRMAPTGRM7
SCHEMBL25464184 0.81 GRM7 (0.73) TSHRGRM7
SCHEMBL25968891 0.81 CES2 (0.52) POLBCCR1TSHRMAPTGRM7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224163-B1 USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-03-30 EP disclosed
CN-1184964-C Use of carbonylamino derivatives against CNS disorders HOFFMANN LA ROCHE (CH) 2005-01-19 CN disclosed
US-6548522-B1 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide HOFFMANN-LA ROCHE INC. 2003-04-15 US disclosed
EP-1224163-A1 USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001027070-A1 USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-19 WO disclosed